Explained herein are pharmaceutical packaging systems which stop oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate prescription drugs, this kind of programs which includes a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeabilit